ストックスクリーナーアプリを入手
18.83
4.46%
-0.88
アフターアワーズ：
19.04
0.21
+1.12%
前日終値:
$19.71
開ける：
$19.07
24時間の取引高:
2.71M
Relative Volume:
1.29
時価総額：
$1.89B
収益：
$352.57M
当期純損益:
$-143.01M
株価収益率:
-10.40
EPS:
-1.81
ネットキャッシュフロー:
$-153.40M
1週間 パフォーマンス:
-13.31%
1か月 パフォーマンス:
+7.42%
6か月 パフォーマンス:
-27.35%
1年 パフォーマンス:
-37.88%
1日の値動き範囲:
$18.64
$19.49
1週間の範囲:
$18.64
$22.05
52週間の値動き範囲:
$13.53
$35.25
Beam Therapeutics Inc Stock (BEAM) Company Profile
名前
Beam Therapeutics Inc
セクター
電話
857-327-8775
住所
26 LANDSDOWNE STREET, CAMBRIDGE, MA
BEAM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BEAM
Beam Therapeutics Inc
|
18.83 | 1.98B | 352.57M | -143.01M | -153.40M | -1.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Beam Therapeutics Inc Stock (BEAM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-28 | アップグレード | BofA Securities | Neutral → Buy |
| 2025-03-10 | アップグレード | Scotiabank | Sector Perform → Sector Outperform |
| 2025-01-29 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2024-11-06 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-10-16 | 開始されました | Scotiabank | Sector Outperform |
| 2024-07-23 | 開始されました | H.C. Wainwright | Buy |
| 2024-01-29 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-12-15 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-12-08 | ダウングレード | Jefferies | Buy → Hold |
| 2023-10-20 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2023-10-20 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2023-03-21 | 開始されました | Bernstein | Mkt Perform |
| 2023-02-01 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-12-20 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2022-12-13 | 開始されました | Citigroup | Buy |
| 2022-06-17 | 開始されました | BMO Capital Markets | Market Perform |
| 2022-04-28 | 開始されました | Credit Suisse | Neutral |
| 2022-01-05 | 開始されました | Guggenheim | Buy |
| 2021-10-19 | 開始されました | SVB Leerink | Outperform |
| 2021-09-24 | 再開されました | Stifel | Buy |
| 2021-09-10 | 開始されました | BofA Securities | Buy |
| 2021-05-11 | 開始されました | Redburn | Buy |
| 2021-05-04 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2021-03-01 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2021-02-16 | 開始されました | Wells Fargo | Overweight |
| 2021-01-29 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-01-06 | 開始されました | Stifel | Hold |
| 2020-08-05 | 開始されました | William Blair | Outperform |
| 2020-03-02 | 開始されました | Barclays | Overweight |
| 2020-03-02 | 開始されました | JP Morgan | Overweight |
| 2020-03-02 | 開始されました | Jefferies | Buy |
| 2020-03-02 | 開始されました | Wedbush | Outperform |
すべてを表示
Beam Therapeutics Inc (BEAM) 最新ニュース
What are the latest earnings results for Beam Therapeutics Inc.Expert Picks Insights For Fast Growth - jammulinksnews.com
Fmr llc sells Beam therapeutics (BEAM) shares for $991667 By Investing.com - Investing.com India
Is Beam Therapeutics Inc. a growth stock or a value stockSwing Trade Opportunities From AI Tools - jammulinksnews.com
Published on: 2025-08-01 11:56:15 - metal.it
What is Beam Therapeutics Inc. company’s growth strategyMarket Forecast Opportunities For Every Investor - jammulinksnews.com
Is it the right time to buy Beam Therapeutics Inc. stockEntry Signal Growth Plan For Every Investor - jammulinksnews.com
What makes Beam Therapeutics Inc. stock price move sharplyChart Pattern Trend Scanner With Low Risk - jammulinksnews.com
How volatile is Beam Therapeutics Inc. stock compared to the marketValue Investing Picks For Consistent Profits - jammulinksnews.com
Beam Therapeutics Inc. stock trendline breakdownReal Time Alerts Based on AI Prediction Triggered - metal.it
Why Beam Therapeutics Inc. stock attracts strong analyst attentionReal-Time Trade Insights Spark Market Reactions - metal.it
Will Beam Therapeutics Inc. Hold Gains Into ClosePotential Breakout Stock List Published This Week - metal.it
Will Beam Therapeutics Inc. (BEAM) Report Negative Q2 Earnings? What You Should Know - Yahoo Finance
Beam Therapeutics Inc. Hits Oversold Level on RSI IndicatorReliable Investment Entry Signals Confirmed by Charts - metal.it
Published on: 2025-07-29 04:04:17 - metal.it
Competitive Positioning of Beam Therapeutics Inc.: Is It Leading or LaggingAlpha Focused Technical Trade Signals Gain Attention - metal.it
How many analysts rate Beam Therapeutics Inc. as a “Buy”Get expert advice on portfolio optimization - jammulinksnews.com
When is Beam Therapeutics Inc. stock expected to show significant growthHigh-velocity capital appreciation - jammulinksnews.com
What is the risk reward ratio of investing in Beam Therapeutics Inc. stockFree Trend-Following Techniques - jammulinksnews.com
What is the dividend policy of Beam Therapeutics Inc. stockFree Market Volatility Navigation Tips - jammulinksnews.com
Is Beam Therapeutics Inc. stock overvalued or undervaluedAchieve rapid wealth accumulation with smart picks - jammulinksnews.com
Why is Beam Therapeutics Inc. stock attracting strong analyst attentionFree Consultation - jammulinksnews.com
Published on: 2025-07-27 19:29:01 - jammulinksnews.com
Is Beam Therapeutics Inc. Stock a Smart Buy in 2025 Investment Analysis InsideFree Real-Time Trading Opportunities - beatles.ru
What drives Beam Therapeutics Inc. stock priceSky-high profits - PrintWeekIndia
Will Beam Therapeutics Inc. stock benefit from interest rate changesFree Market Dynamics Reports - jammulinksnews.com
What makes Beam Therapeutics Inc. stock attractive to long term investorsSuperior stock selection - jammulinksnews.com
What institutions are buying Beam Therapeutics Inc. stock nowOutperformance with explosive growth - jammulinksnews.com
What analysts say about Beam Therapeutics Inc. stockFree Popular Stock Recommendations - PrintWeekIndia
Trading (BEAM) With Integrated Risk Controls - news.stocktradersdaily.com
Can Beam Therapeutics Inc. stock recover from recent declineFree Smart Trading Workshop - jammulinksnews.com
Beam Therapeutics Inc. Stock Analysis and ForecastFree Stock Movement Tracking - Autocar Professional
Is Beam Therapeutics Inc. a good long term investmentRobust financial gains - jammulinksnews.com
Sickle Cell Disease Market Set to Grow Substantially Through 2034, DelveInsight Projects | Sanofi, CSL Behring, ITB-Med LLC, Novo Nordisk A/S, Fortrea, Inc., Novartis, Afimmune, Pfizer, ADDMEDICA SASA - The Globe and Mail
Beam Therapeutics (BEAM) Announces Acquisition of an Early-Stage Life Sciences Company - MSN
Beam Therapeutics Inc (BEAM) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
0.15%
大文字化:
|
ボリューム (24 時間):